No risk adjustment or stratification

This measure identifies moderate and severe complications among term infants who enter labor without preexisting fetal conditions (morbidity outcome measure).  The scope of the measure includes both maternal and neonatal care and is appropriate for all levels of hospital care and is collected for a full year time period.  The measure is designed to highlight processes of both obstetric and neonatal care that can be improved while recognizing that not all complications can be avoided.  As an infant outcome measure it can also serve as a balancing measure for interventions targ

The Use of Pharmacotherapy for Opioid Use Disorder measure evaluates the percentage of Medicaid or Medicare-Medicaid participants, aged 18 years and older, who have been diagnosed with an opioid use disorder (OUD) who filled a prescription for, were administered, or dispensed, a Food and Drug Administration (FDA)-approved medication to treat or manage OUD during the measurement year.

This metric is designed to measure the critical care transport team's utilization of waveform capnography during critical care medical transport.  Waveform capnography has evolved as the standard for the safe placement and maintenance of advanced airways (e.g., endotracheal tubes) in adult and pediatric patients.  The metric specifically focuses on transported patients with advanced airways in whom continuous waveform capnography is appropriately used.  This metric is stratified by age into the following three categories: neonatal (defined as infants <29 days), pediatric (